Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Investors and industry watchers are closely monitoring CytomX Therapeutics, Inc. (NASDAQ: CTMX), which has seen a significant uptick in its stock price...